Condition (MeSH)
Wheat Hypersensitivity
ClinicalTrials.gov lists 20 trials for Wheat Hypersensitivity or a narrower condition beneath it. Alladapt Immunotherapeutics, Inc. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Wheat Hypersensitivity itself; the rest are tagged with a narrower condition beneath it.
When did Wheat Hypersensitivity trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2024 | 1 |
| 2023 | 3 |
| 2022 | 1 |
| 2021 | 1 |
| 2019 | 2 |
| 2018 | 1 |
| 2017 | 4 |
| 2014 | 1 |
| 2013 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Wheat Hypersensitivity trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 3 |
| Phase 2 | 1 |
| Not applicable | 10 |
| Observational | 5 |
How many Wheat Hypersensitivity trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Completed | 9 |
| Suspended | 1 |
| Terminated | 3 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Wheat Hypersensitivity trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alladapt Immunotherapeutics, Inc. | 2 |
| Candid Therapeutics | 1 |
| Longbio Pharma (Suzhou) Co., Ltd. | 1 |
| Lyckeby Starch AB | 1 |
Which drugs are being tested for Wheat Hypersensitivity? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Wheat | 1 |
| Cizutamig | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| ADP101 | 1 |
| Wheat OIT | 1 |
| LP-003 Injection | 1 |
| Low dose ADP101 | 1 |
| High dose ADP101 | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Wheat Hypersensitivity trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Anaphylaxis | 2 | 1 |
| Asthma | 2 | 1 |
| Anaphylactic Reaction | 1 | 1 |
| Gastroenteritis | 1 | 1 |
| Pneumonia | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Wheat Hypersensitivity? (34)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, international, multicentre study. | The lancet. Gastroenterology & hepatology | 2024 | Yes |
| Two randomized crossover multicenter studies investigating gastrointestinal symptoms after bread consumption in individuals with noncoeliac wheat sensitivity: do wheat species and fermentation type matter? | The American journal of clinical nutrition | 2024 | Yes |
| Autoimmunity Features in Patients With Non-Celiac Wheat Sensitivity. | The American journal of gastroenterology | 2021 | Yes |
| Gynecological Disorders in Patients with Non-celiac Wheat Sensitivity. | Digestive diseases and sciences | 2021 | Yes |
| Frequency and Clinical Aspects of Neurological and Psychiatric Symptoms in Patients with Non-Celiac Wheat Sensitivity. | Nutrients | 2021 | Yes |
Showing 5 of 34 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.